Biofrontera Inc. (BFRI) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Biofrontera Inc. (BFRI) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $11.3M, listed on NASDAQ, employing roughly 92 people, carrying a beta of 0.91 to the broader market. Biofrontera Inc. Led by Hermann Luebbert, public since 2021-10-29.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for BFRI as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.